|
| |
GAD
| Symbol: | GAD | | Name(s): | GAD (Glutamate decarboxylase 1); calmodulin binding | | Type: | protein-coding | | Organism: | Arabidopsis thaliana | | Synonyms: | GAD1, GLUTAMATE DECARBOXYLASE, Glutamate decarboxylase 1, MKP11.30, MKP11_30 | | Links: |
Pubmed,
Entrez Gene,
Map Viewer.
|
Gene Information from Publications |
| Publication Link |
Summary of findings |
| 17392553 |
Antibody titers to this enzyme identify two subgroups of patients with adult-onset autoimmune diabetes having distinct clinical, autoimmune, and genetic features. |
| 15604684 |
Insertion mutants of GAD1 revealed that GABA levels in roots were drastically reduced compared with those in the wild type. |
Press Releases on GAD:
|
 |
| Henry Ford West Bloomfield Hospital Launches Gene Therapy Study for Parkinson's Disease |
6th October, 2009 |
Henry Ford Health System |
WEST BLOOMFIELD, Mich., Oct. 6 /PRNewswire/ -- Henry Ford West Bloomfield Hospital is embarking on a research study for advanced Parkinson's disease using a state-of-the-art
|
| Diamyd Makes Investment in Time-to-Market |
1st October, 2009 |
Diamyd Medical AB (publ) |
STOCKHOLM, October 1 /PRNewswire-FirstCall/ -- Diamyd Medical announces
today that the company has signed an agreement with Inclinix Inc., North
Carolina, for accelerated recruitment of
|
| Diamyd(R) Phase III Study Approved for Younger Patients in the US |
8th June, 2009 |
Diamyd Medical AB (publ) |
STOCKHOLM, June 8 /PRNewswire-FirstCall/ -- Diamyd Medical reported today
that the company has received approval from the US Food and Drug
Administration (FDA) to include children with type 1
|
| Surveyed Psychiatrists and PCPs Expect to Increase Their First-Line Use of SNRIs Over the Next Two Years for the Treatment of Generalized Anxiety Disorder |
2nd June, 2009 |
Decision Resources |
Only 41 Percent of Newly Diagnosed Patients Receive a Drug Within One Year of Their First Diagnosis, According to a New Report from Decision Resources
Patient-Flow
|
| FDA Advisory Committee Documents for SEROQUEL XR Available on AstraZeneca Web Site |
3rd April, 2009 |
AstraZeneca |
WILMINGTON, Del., April 3 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) is aware that earlier today, the US Food and Drug Administration (FDA) posted to its web site -- and subsequently removed
|
GAD results (if any) from reagent suppliers | 
|
Search Bioportfolio and other Life Science Sites for GAD,
or search for GAD on BioPortfolio's antibody search engine.
This page has been viewed 259 times
Recent Search Terms used to find this page: gad test for type i | glutamate decarboxylase | gad antibody test elisa | symbol for Gad | Glutamic acid decarboxylase antibody test | diabetes type 1 - Glutamic acid decarboxylase GAD antibody test | gad antibody test results | test result glutamate decarboxylase 65 antibody | Glutamate Acid Decarboxylase (GAD) test | .
Resources from the NCBI used on this page, NCBI's standard disclaimer applies.
|
